首页 > 最新文献

Surgery最新文献

英文 中文
Response to Letter to the Editor. 对给编辑的信的回应。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-12-04 DOI: 10.1016/j.surg.2024.10.009
Victoria Lai
{"title":"Response to Letter to the Editor.","authors":"Victoria Lai","doi":"10.1016/j.surg.2024.10.009","DOIUrl":"10.1016/j.surg.2024.10.009","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108918"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inequalities in quality metrics for colorectal cancer surgery in older adults: A retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program registry. 老年人结直肠癌手术质量指标的不平等:利用美国外科学院国家外科质量改进计划登记处进行的一项回顾性队列研究。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-24 DOI: 10.1016/j.surg.2024.09.027
Tiago Ribeiro, Adom Bondzi-Simpson, Tyler R Chesney, Sami A Chadi, Natalie Coburn, Julie Hallet

Background: With a growing proportion of patients undergoing surgery for colorectal cancer being older adults, it is unknown whether traditional quality metrics are achieved as often compared with younger adults. This work was done with a view to understand tailoring needs of quality metrics for older adults with colorectal cancer.

Methods: This retrospective cohort study used the American College of Surgeons National Surgical Quality Improvement Program registry to identify adults (≥18 years) between 2016 and 2021 who underwent elective colorectal cancer surgery for nonmetastatic cancer. older adults was defined as adults ≥65 years. The association between older adults and attainment of consensus quality metrics were evaluated using multivariable logistic regression adjusting for patient, cancer, and treatment factors.

Results: Of 46,159 patients undergoing elective colon cancer resection, 18,592 (40.3%) were older adults. Being an older adult was independently associated with a 14% reduction in odds of harvest of ≥12 nodes and 4.3 times increase in odds of 30-day mortality. Of 9,106 patients undergoing elective rectal cancer resection 5,143 (56.5%) were older adults. Being an older adult was independently associated with a 19% reduction in odds of harvest of ≥12 nodes, 2.3 times increase in odds of 30-day mortality and a 44% reduction in odds of receiving neoadjuvant radiation. Findings were robust to sensitivity analyses of alternate methods of handling missing data and alternate analytic approaches.

Conclusion: Given unique needs of the older adult population, interpretation of disparities in quality metrics is challenging because of an inability to differentiate between patient factors, tailored care, or bias. Monitoring and reporting of quality metrics for older adults need to be re-evaluated with consideration to stratification, unique benchmarks, and older adult-specific quality metrics.

背景:随着接受结直肠癌手术的患者中老年人所占比例越来越大,与年轻人相比,传统的质量指标是否能经常达到还不得而知。这项工作旨在了解老年人结直肠癌患者对质量指标的定制需求:这项回顾性队列研究利用美国外科医生学会国家外科质量改进计划登记册,对 2016 年至 2021 年间因非转移性癌症接受择期结直肠癌手术的成年人(≥18 岁)进行识别。使用多变量逻辑回归评估了老年人与达到共识质量指标之间的关系,并对患者、癌症和治疗因素进行了调整:结果:在接受择期结肠癌切除术的 46,159 名患者中,有 18,592 名(40.3%)是老年人。老年人与切除结节≥12个的几率降低14%和30天死亡率增加4.3倍密切相关。在9106名接受择期直肠癌切除术的患者中,有5143人(56.5%)是老年人。老年人与切除≥12个结节的几率降低19%、30天死亡率增加2.3倍以及接受新辅助放射治疗的几率降低44%有独立关联。研究结果对处理缺失数据的替代方法和替代分析方法的敏感性分析具有稳健性:鉴于老年人群的特殊需求,对质量指标差异的解释具有挑战性,因为无法区分患者因素、定制护理或偏见。对老年人质量指标的监测和报告需要重新评估,并考虑分层、独特的基准和老年人特定的质量指标。
{"title":"Inequalities in quality metrics for colorectal cancer surgery in older adults: A retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program registry.","authors":"Tiago Ribeiro, Adom Bondzi-Simpson, Tyler R Chesney, Sami A Chadi, Natalie Coburn, Julie Hallet","doi":"10.1016/j.surg.2024.09.027","DOIUrl":"10.1016/j.surg.2024.09.027","url":null,"abstract":"<p><strong>Background: </strong>With a growing proportion of patients undergoing surgery for colorectal cancer being older adults, it is unknown whether traditional quality metrics are achieved as often compared with younger adults. This work was done with a view to understand tailoring needs of quality metrics for older adults with colorectal cancer.</p><p><strong>Methods: </strong>This retrospective cohort study used the American College of Surgeons National Surgical Quality Improvement Program registry to identify adults (≥18 years) between 2016 and 2021 who underwent elective colorectal cancer surgery for nonmetastatic cancer. older adults was defined as adults ≥65 years. The association between older adults and attainment of consensus quality metrics were evaluated using multivariable logistic regression adjusting for patient, cancer, and treatment factors.</p><p><strong>Results: </strong>Of 46,159 patients undergoing elective colon cancer resection, 18,592 (40.3%) were older adults. Being an older adult was independently associated with a 14% reduction in odds of harvest of ≥12 nodes and 4.3 times increase in odds of 30-day mortality. Of 9,106 patients undergoing elective rectal cancer resection 5,143 (56.5%) were older adults. Being an older adult was independently associated with a 19% reduction in odds of harvest of ≥12 nodes, 2.3 times increase in odds of 30-day mortality and a 44% reduction in odds of receiving neoadjuvant radiation. Findings were robust to sensitivity analyses of alternate methods of handling missing data and alternate analytic approaches.</p><p><strong>Conclusion: </strong>Given unique needs of the older adult population, interpretation of disparities in quality metrics is challenging because of an inability to differentiate between patient factors, tailored care, or bias. Monitoring and reporting of quality metrics for older adults need to be re-evaluated with consideration to stratification, unique benchmarks, and older adult-specific quality metrics.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108870"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142508436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice makes perfect: Immersion endoscopy training in colorectal surgery focuses on quantity and quality. 熟能生巧:结直肠外科浸入式内窥镜培训注重数量和质量。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-22 DOI: 10.1016/j.surg.2024.09.026
Ameera J M S AlHasan, Sarah Mills
{"title":"Practice makes perfect: Immersion endoscopy training in colorectal surgery focuses on quantity and quality.","authors":"Ameera J M S AlHasan, Sarah Mills","doi":"10.1016/j.surg.2024.09.026","DOIUrl":"10.1016/j.surg.2024.09.026","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108869"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142508444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: Routine use of robotics in cholecystectomy: Another brick in the wall. 致编辑的信:在胆囊切除术中常规使用机器人技术:又一堵墙。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-11-10 DOI: 10.1016/j.surg.2024.09.045
Dimitrios Moris, Piyush Gupta, Pejman Radkani
{"title":"Letter to the editor: Routine use of robotics in cholecystectomy: Another brick in the wall.","authors":"Dimitrios Moris, Piyush Gupta, Pejman Radkani","doi":"10.1016/j.surg.2024.09.045","DOIUrl":"10.1016/j.surg.2024.09.045","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108906"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142626821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer. IMMUNOREACT 8:经肛门切除术治疗临床 N0 直肠癌患者局部肿瘤扩散的免疫标记物。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-11-20 DOI: 10.1016/j.surg.2024.09.043
Giulia Becherucci, Cesare Ruffolo, Melania Scarpa, Federico Scognamiglio, Astghik Stepanyan, Isacco Maretto, Andromachi Kotsafti, Ottavia De Simoni, Pierluigi Pilati, Boris Franzato, Antonio Scapinello, Francesca Bergamo, Marco Massani, Tommaso Stecca, Anna Pozza, Ivana Cataldo, Stefano Brignola, Valerio Pellegrini, Matteo Fassan, Vincenza Guzzardo, Luca Dal Santo, Roberta Salmaso, Ceccon Carlotta, Angelo Paolo Dei Tos, Imerio Angriman, Gaya Spolverato, Valentina Chiminazzo, Silvia Negro, Chiara Vignotto, Francesco Marchegiani, Luca Facci, Giorgio Rivella, Quoc Riccardo Bao, Andrea Baldo, Salvatore Pucciarelli, Maurizio Zizzo, Gianluca Businello, Beatrice Salmaso, Dario Parini, Giovanni Pirozzolo, Alfonso Recordare, Giovanni Tagliente, Giovanni Bordignon, Roberto Merenda, Laurino Licia, Giulia Pozza, Mario Godina, Isabella Mondi, Daunia Verdi, Corrado Da Lio, Silvio Guerriero, Alessandra Piccioli, Giuseppe Portale, Matteo Zuin, Chiara Cipollari, Giulia Noaro, Roberto Cola, Salvatore Candioli, Laura Gavagna, Fabio Ricagna, Monica Ortenzi, Mario Guerrieri, Monica Tomassi, Umberto Tedeschi, Laura Marinelli, Mattia Barbareschi, Giovanni Bertalot, Alberto Brolese, Lavinia Ceccarini, Michele Antoniutti, Andrea Porzionato, Marco Agostini, Francesco Cavallin, Gaia Tussardi, Barbara Di Camillo, Romeo Bardini, Ignazio Castagliuolo, Marco Scarpa

Background: Transanal excision of rectal cancer can be considered the definitive surgical treatment if the depth spread is T1 or lower, and the lesion is completely included within the resection margin. This study aims to analyze the immune microenvironment in healthy rectal mucosa as a possible predictor of tumor infiltration depth, lateral tumor spread, and recurrence of rectal cancer after transanal local excision.

Methods: This study is a subanalysis of data from the IMMUNOREACT 1 and 2 trials (NCT04915326 and NCT04917263, respectively) including all the patients who underwent transanal excision of rectal cancer. This multicentric study collected healthy mucosa surrounding the neoplasms of patients with rectal cancer. A panel of immune markers was investigated at immunohistochemistry: CD3, CD4, CD8, CD8β, Tbet, FoxP3, PD-L1, MSH6, and PMS2 and CD80. Flow cytometry determined the proportion of epithelial cells expressing CD80, CD86, CD40, HLA ABC or HLA DR and the proportion of activated CD8+ T cells, CD4+ Th1 cells, and Treg.

Results: Receiver operating characteristic curve analysis for predicting deep tumor spread showed an area under the curve of 0.70 (95% confidence interval: 0.60-0.80) for CD25+FoxP3+ cell rate and 0.74 (95% confidence interval: 0.53-0.92) for CK+CD86+ cell rate. Receiver operating characteristic curve analysis for predicting lateral tumor spread showed an area under the curve of 0.82 (95% confidence interval: 0.61-0.99) for CD8+CD38+ MFI, 0.96 (95% confidence interval: 0.85-0.99) for CD8β infiltration, and 0.97 (95% confidence interval: 0.87-0.99) for CK+HLAabc+ cell rate. Receiver operating characteristic curve analysis for predicting recurrence showed an area under the curve of 0.93 (95% confidence interval: 0.76-0.99) for CD8+CD38+ MFI and 0.94 (95% confidence interval: 0.78-0.99) for CD8+CD28+ MFI. Low CD8+CD38+ MFI and low CD8+CD28+ MFI were associated with shorter disease-free survival (P = .025 and P = .021, respectively).

Conclusion: Our study showed that the association between the high proportion of epithelial cells acting as presenting cells and deep or lateral tumor spread may be explained by the presence of a greater tumor load at the site. Moreover, it showed that weak activation of CD8+ T cells within the rectal mucosa is associated with lateral tumor spread and eventually a higher recurrence rate. The mucosal level of CD8β infiltration detected at immunohistochemistry might be tested as a marker of lateral tumor spread and potentially translated into clinical practice.

背景:如果直肠癌的扩散深度为T1或更低,且病灶完全包括在切除边缘内,则经肛门切除直肠癌可被视为最终的手术治疗方法。本研究旨在分析健康直肠粘膜的免疫微环境,以此作为经肛局部切除术后肿瘤浸润深度、肿瘤侧向扩散和直肠癌复发的可能预测因素:本研究是对 IMMUNOREACT 1 和 2 试验(分别为 NCT04915326 和 NCT04917263)数据的子分析,包括所有接受经肛门直肠癌切除术的患者。这项多中心研究收集了直肠癌患者肿瘤周围的健康粘膜。通过免疫组化对一系列免疫标记物进行了研究:CD3、CD4、CD8、CD8β、Tbet、FoxP3、PD-L1、MSH6、PMS2 和 CD80。流式细胞术测定了表达 CD80、CD86、CD40、HLA ABC 或 HLA DR 的上皮细胞比例,以及活化的 CD8+ T 细胞、CD4+ Th1 细胞和 Treg 的比例:预测肿瘤深部扩散的接收者操作特征曲线分析显示,CD25+FoxP3+细胞率的曲线下面积为0.70(95%置信区间:0.60-0.80),CK+CD86+细胞率的曲线下面积为0.74(95%置信区间:0.53-0.92)。预测肿瘤横向扩散的接收者操作特征曲线分析显示,CD8+CD38+ MFI 的曲线下面积为 0.82(95% 置信区间:0.61-0.99),CD8β浸润的曲线下面积为 0.96(95% 置信区间:0.85-0.99),CK+HLAabc+ 细胞率的曲线下面积为 0.97(95% 置信区间:0.87-0.99)。预测复发的接收者操作特征曲线分析显示,CD8+CD38+ MFI 的曲线下面积为 0.93(95% 置信区间:0.76-0.99),CD8+CD28+ MFI 的曲线下面积为 0.94(95% 置信区间:0.78-0.99)。低 CD8+CD38+ MFI 和低 CD8+CD28+ MFI 与较短的无病生存期相关(分别为 P = .025 和 P = .021):我们的研究表明,作为呈现细胞的上皮细胞比例高与肿瘤向深部或侧部扩散之间的关联可能是由于该部位存在较大的肿瘤负荷。此外,研究还表明,直肠粘膜内 CD8+ T 细胞的弱激活与肿瘤的侧向扩散以及最终的高复发率有关。免疫组化检测到的 CD8β 浸润的粘膜水平可作为肿瘤侧向扩散的标志物进行检测,并有可能应用于临床实践。
{"title":"IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.","authors":"Giulia Becherucci, Cesare Ruffolo, Melania Scarpa, Federico Scognamiglio, Astghik Stepanyan, Isacco Maretto, Andromachi Kotsafti, Ottavia De Simoni, Pierluigi Pilati, Boris Franzato, Antonio Scapinello, Francesca Bergamo, Marco Massani, Tommaso Stecca, Anna Pozza, Ivana Cataldo, Stefano Brignola, Valerio Pellegrini, Matteo Fassan, Vincenza Guzzardo, Luca Dal Santo, Roberta Salmaso, Ceccon Carlotta, Angelo Paolo Dei Tos, Imerio Angriman, Gaya Spolverato, Valentina Chiminazzo, Silvia Negro, Chiara Vignotto, Francesco Marchegiani, Luca Facci, Giorgio Rivella, Quoc Riccardo Bao, Andrea Baldo, Salvatore Pucciarelli, Maurizio Zizzo, Gianluca Businello, Beatrice Salmaso, Dario Parini, Giovanni Pirozzolo, Alfonso Recordare, Giovanni Tagliente, Giovanni Bordignon, Roberto Merenda, Laurino Licia, Giulia Pozza, Mario Godina, Isabella Mondi, Daunia Verdi, Corrado Da Lio, Silvio Guerriero, Alessandra Piccioli, Giuseppe Portale, Matteo Zuin, Chiara Cipollari, Giulia Noaro, Roberto Cola, Salvatore Candioli, Laura Gavagna, Fabio Ricagna, Monica Ortenzi, Mario Guerrieri, Monica Tomassi, Umberto Tedeschi, Laura Marinelli, Mattia Barbareschi, Giovanni Bertalot, Alberto Brolese, Lavinia Ceccarini, Michele Antoniutti, Andrea Porzionato, Marco Agostini, Francesco Cavallin, Gaia Tussardi, Barbara Di Camillo, Romeo Bardini, Ignazio Castagliuolo, Marco Scarpa","doi":"10.1016/j.surg.2024.09.043","DOIUrl":"10.1016/j.surg.2024.09.043","url":null,"abstract":"<p><strong>Background: </strong>Transanal excision of rectal cancer can be considered the definitive surgical treatment if the depth spread is T1 or lower, and the lesion is completely included within the resection margin. This study aims to analyze the immune microenvironment in healthy rectal mucosa as a possible predictor of tumor infiltration depth, lateral tumor spread, and recurrence of rectal cancer after transanal local excision.</p><p><strong>Methods: </strong>This study is a subanalysis of data from the IMMUNOREACT 1 and 2 trials (NCT04915326 and NCT04917263, respectively) including all the patients who underwent transanal excision of rectal cancer. This multicentric study collected healthy mucosa surrounding the neoplasms of patients with rectal cancer. A panel of immune markers was investigated at immunohistochemistry: CD3, CD4, CD8, CD8β, Tbet, FoxP3, PD-L1, MSH6, and PMS2 and CD80. Flow cytometry determined the proportion of epithelial cells expressing CD80, CD86, CD40, HLA ABC or HLA DR and the proportion of activated CD8+ T cells, CD4+ Th1 cells, and Treg.</p><p><strong>Results: </strong>Receiver operating characteristic curve analysis for predicting deep tumor spread showed an area under the curve of 0.70 (95% confidence interval: 0.60-0.80) for CD25+FoxP3+ cell rate and 0.74 (95% confidence interval: 0.53-0.92) for CK+CD86+ cell rate. Receiver operating characteristic curve analysis for predicting lateral tumor spread showed an area under the curve of 0.82 (95% confidence interval: 0.61-0.99) for CD8+CD38+ MFI, 0.96 (95% confidence interval: 0.85-0.99) for CD8β infiltration, and 0.97 (95% confidence interval: 0.87-0.99) for CK+HLAabc+ cell rate. Receiver operating characteristic curve analysis for predicting recurrence showed an area under the curve of 0.93 (95% confidence interval: 0.76-0.99) for CD8+CD38+ MFI and 0.94 (95% confidence interval: 0.78-0.99) for CD8+CD28+ MFI. Low CD8+CD38+ MFI and low CD8+CD28+ MFI were associated with shorter disease-free survival (P = .025 and P = .021, respectively).</p><p><strong>Conclusion: </strong>Our study showed that the association between the high proportion of epithelial cells acting as presenting cells and deep or lateral tumor spread may be explained by the presence of a greater tumor load at the site. Moreover, it showed that weak activation of CD8+ T cells within the rectal mucosa is associated with lateral tumor spread and eventually a higher recurrence rate. The mucosal level of CD8β infiltration detected at immunohistochemistry might be tested as a marker of lateral tumor spread and potentially translated into clinical practice.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108902"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer. 肌肉浸润性膀胱癌肿瘤抗原特征和mRNA疫苗选择的免疫亚型鉴定
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI: 10.1016/j.surg.2024.10.017
Zhijie Xu, Yunfei Wu, Yanfeng Bai, Xiaoyi Chen, Guanghou Fu, Baiye Jin
<p><strong>Background: </strong>Muscle-invasive bladder cancer continues to lack reliable diagnostic and prognostic biomarkers. Recently, tumor vaccines targeting specific molecules have emerged as a promising treatment in inhibiting tumor progression, which was rekindled under the background of coronavirus disease-2019 pandemic. However, the application of mRNA vaccine targeting muscle-invasive bladder cancer-specific antigens remains limited, and there has been a lack of comprehensive studies or validations to identify suitable patient subgroups for vaccination. This study aims to explore novel muscle-invasive bladder cancer antigen signatures to identify patients most likely to benefit from vaccination.</p><p><strong>Methods: </strong>Gene expression profiles of muscle-invasive bladder cancer samples, along with corresponding clinical data, were retrieved from the Cancer Genome Atlas Program. The least absolute shrinkage and selection operator model was applied to develop signatures for stratifying muscle-invasive bladder cancer patients. Prognostic accuracy of each factor was assessed using receiver operating characteristic analysis. Tumor Immune Estimation Resource was employed to visualize the relationship between the proportion of antigen-presenting cells and the expression of selected genes. The CIBERSORT and WGCNA R packages were used to identify differences in immune infiltration levels across muscle-invasive bladder cancer subgroups. Additionally, the STRING database and Cytoscape were used to construct the protein-protein interaction network. CCK-8 and colony formation assays were employed in invitro experiments.</p><p><strong>Results: </strong>A total of 49 potential tumor antigens were identified. Using least absolute shrinkage and selection operator Cox regression, 14 tumor antigens were selected to develop a risk evaluation signature. The risk score signature can serve as a valuable tool for predicting the outcomes of muscle-invasive bladder cancer patients. Based on differential clinical, molecular, and immune-related gene profiles, muscle-invasive bladder cancer patients were classified into 2 subtypes: the immune "cold" subtype (immune score 1) and the immune "hot" subtype (immune score 2). The immune score signature, developed using a logistic score model, effectively distinguishes between patients more likely to belong to immune score 1 or 2. Notably, patients with a high risk score exhibited a higher proportion of immune score 2 compared to those with a low risk score. Additionally, the prognostic accuracy was significantly enhanced when the risk score and immune score were combined. Different tumor subtypes displayed distinct immune landscapes and signaling pathways. Moreover, novel tumor antigens associated with oxidative stress were identified.</p><p><strong>Conclusion: </strong>The risk score and immune score signatures based on tumor antigens have identified potential effective neo-antigens for the development of mRNA v
背景:肌肉浸润性膀胱癌仍然缺乏可靠的诊断和预后生物标志物。最近,针对特定分子的肿瘤疫苗成为抑制肿瘤进展的一种有希望的治疗方法,在新冠肺炎大流行的背景下重新点燃。然而,靶向肌肉侵袭性膀胱癌特异性抗原的mRNA疫苗的应用仍然有限,并且缺乏全面的研究或验证来确定适合接种疫苗的患者亚群。本研究旨在探索新的肌肉侵袭性膀胱癌抗原特征,以确定最有可能从疫苗接种中受益的患者。方法:从癌症基因组图谱计划中检索肌肉浸润性膀胱癌样本的基因表达谱以及相应的临床数据。应用最小绝对收缩和选择算子模型建立肌肉浸润性膀胱癌患者的分层特征。采用受试者工作特征分析评估各因素的预后准确性。利用肿瘤免疫估计资源可视化抗原呈递细胞比例与选定基因表达之间的关系。CIBERSORT和WGCNA R包被用于识别肌肉浸润性膀胱癌亚组间免疫浸润水平的差异。此外,利用STRING数据库和Cytoscape构建蛋白-蛋白相互作用网络。体外实验采用CCK-8法和菌落形成法。结果:共鉴定出49种潜在的肿瘤抗原。采用最小绝对收缩和选择算子Cox回归,选择14种肿瘤抗原形成风险评价特征。风险评分特征可以作为预测肌肉浸润性膀胱癌患者预后的有价值的工具。基于不同的临床、分子和免疫相关基因谱,将肌肉浸润性膀胱癌患者分为2个亚型:免疫“冷”亚型(免疫评分1)和免疫“热”亚型(免疫评分2)。使用logistic评分模型开发的免疫评分特征有效区分了更可能属于免疫评分1或2的患者。值得注意的是,与低风险评分的患者相比,高风险评分的患者表现出更高比例的免疫评分2。此外,当风险评分和免疫评分相结合时,预后准确性显着提高。不同的肿瘤亚型表现出不同的免疫景观和信号通路。此外,还发现了与氧化应激相关的新型肿瘤抗原。结论:基于肿瘤抗原的风险评分和免疫评分特征为开发针对肌肉浸润性膀胱癌的mRNA疫苗提供了潜在的有效新抗原。低风险评分和免疫评分1亚型的患者更有可能从mRNA疫苗接种中获益。此外,本研究强调了氧化应激在调节mRNA疫苗效力中的关键作用。
{"title":"Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer.","authors":"Zhijie Xu, Yunfei Wu, Yanfeng Bai, Xiaoyi Chen, Guanghou Fu, Baiye Jin","doi":"10.1016/j.surg.2024.10.017","DOIUrl":"10.1016/j.surg.2024.10.017","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Muscle-invasive bladder cancer continues to lack reliable diagnostic and prognostic biomarkers. Recently, tumor vaccines targeting specific molecules have emerged as a promising treatment in inhibiting tumor progression, which was rekindled under the background of coronavirus disease-2019 pandemic. However, the application of mRNA vaccine targeting muscle-invasive bladder cancer-specific antigens remains limited, and there has been a lack of comprehensive studies or validations to identify suitable patient subgroups for vaccination. This study aims to explore novel muscle-invasive bladder cancer antigen signatures to identify patients most likely to benefit from vaccination.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Gene expression profiles of muscle-invasive bladder cancer samples, along with corresponding clinical data, were retrieved from the Cancer Genome Atlas Program. The least absolute shrinkage and selection operator model was applied to develop signatures for stratifying muscle-invasive bladder cancer patients. Prognostic accuracy of each factor was assessed using receiver operating characteristic analysis. Tumor Immune Estimation Resource was employed to visualize the relationship between the proportion of antigen-presenting cells and the expression of selected genes. The CIBERSORT and WGCNA R packages were used to identify differences in immune infiltration levels across muscle-invasive bladder cancer subgroups. Additionally, the STRING database and Cytoscape were used to construct the protein-protein interaction network. CCK-8 and colony formation assays were employed in invitro experiments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 49 potential tumor antigens were identified. Using least absolute shrinkage and selection operator Cox regression, 14 tumor antigens were selected to develop a risk evaluation signature. The risk score signature can serve as a valuable tool for predicting the outcomes of muscle-invasive bladder cancer patients. Based on differential clinical, molecular, and immune-related gene profiles, muscle-invasive bladder cancer patients were classified into 2 subtypes: the immune \"cold\" subtype (immune score 1) and the immune \"hot\" subtype (immune score 2). The immune score signature, developed using a logistic score model, effectively distinguishes between patients more likely to belong to immune score 1 or 2. Notably, patients with a high risk score exhibited a higher proportion of immune score 2 compared to those with a low risk score. Additionally, the prognostic accuracy was significantly enhanced when the risk score and immune score were combined. Different tumor subtypes displayed distinct immune landscapes and signaling pathways. Moreover, novel tumor antigens associated with oxidative stress were identified.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The risk score and immune score signatures based on tumor antigens have identified potential effective neo-antigens for the development of mRNA v","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108926"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parathyroid hormone-based algorithm reduces complications after total thyroidectomy. 基于甲状旁腺激素的算法减少了甲状腺全切除术后的并发症。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-11-29 DOI: 10.1016/j.surg.2024.10.024
Nathalie Chereau, Sebastien Gaujoux, Cecile Ghander, Jean Philippe Bertocchio, Camille Buffet, Fabrice Menegaux
<p><strong>Background: </strong>Hypocalcemia after total thyroidectomy is a frequent complication that can be predicted and best managed by the postoperative measurement of parathyroid hormone levels.</p><p><strong>Methods: </strong>This study included consecutive patients who underwent total thyroidectomy between 2017 and 2022. Hypocalcemia was defined as serum calcium <8.0 mg/dL and hypoparathyroidism as parathyroid hormone <15 pg/mL. After comparing serum calcium levels on postoperative day 1 and intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy in the first period, an algorithm involving routine postoperative oral calcium and alfacalcidol administration in patients with intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy <20 pg/mL was developed and tested during the second period. The rates of symptomatic hypocalcemia, readmission for hypocalcemia, and permanent hypoparathyroidism were compared between the 2 periods.</p><p><strong>Results: </strong>In the first period, 1,965 total thyroidectomies (1,548 women; mean age, 51 years) were performed, including 617 patients (31%) with central neck dissection for thyroid carcinoma. Of 314 patients (16%) who experienced symptomatic hypocalcemia, only 183 (58%) could be predicted using serum calcium levels on postoperative day 1 <8.0 mg/dL. This rate increased to 96% (301 patients) when using intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and serum calcium levels on postoperative day 1 (P < .001). Intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy alone could predict symptomatic hypocalcemia in 90% (282) of patients. Hypoparathyroidism was permanent in 20 patients (1%), with a greater predictive value of intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy over serum calcium levels on postoperative day 1 (18/20 [90%] vs 8/20 [40%], P < .01). Using the intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy-based algorithm and preventive calcium supplementation in the second period of the study, 1,420 total thyroidectomies (1,106 women; mean age, 50 years) were performed, including 392 (28%) cases with central neck dissection for thyroid carcinoma. Only 2.3% (32) patients developed a symptomatic hypocalcemia compared with 16% during the first period (P < .001). Thirty-eight patients (2.7%) experienced readmission after total thyroidectomy before implementation of the supplementation protocol in our study compared with 2 patients (0.01%) after we began using the protocol (P < .001). There was no significant difference in permanent hypoparathyroidism between the 2 periods (1.3% vs 1%) (P = .8).</p><p><strong>Conclusions: </strong>The parathyroid hormone-based algorithm determined by intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and routine preventive administration of oral calcium/calcitriol reduced the risk o
背景:甲状腺全切除术后低钙血症是一种常见的并发症,可以通过术后甲状旁腺激素水平的测量来预测和控制。方法:本研究纳入了2017年至2022年间接受甲状腺全切除术的连续患者。结果:在第一阶段,1965例全甲状腺切除术(1548例妇女;平均年龄51岁,包括617例(31%)因甲状腺癌进行中央颈部清扫的患者。在314例(16%)出现症状性低钙血症的患者中,只有183例(58%)可以通过术后第1天的血清钙水平预测。结论:基于甲状旁腺激素的算法,由全甲状腺切除术后20分钟术中甲状旁腺激素水平确定,常规预防性口服钙/骨化三醇可降低症状性低钙血症和全甲状腺切除术后再入院的风险。
{"title":"Parathyroid hormone-based algorithm reduces complications after total thyroidectomy.","authors":"Nathalie Chereau, Sebastien Gaujoux, Cecile Ghander, Jean Philippe Bertocchio, Camille Buffet, Fabrice Menegaux","doi":"10.1016/j.surg.2024.10.024","DOIUrl":"10.1016/j.surg.2024.10.024","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Hypocalcemia after total thyroidectomy is a frequent complication that can be predicted and best managed by the postoperative measurement of parathyroid hormone levels.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study included consecutive patients who underwent total thyroidectomy between 2017 and 2022. Hypocalcemia was defined as serum calcium &lt;8.0 mg/dL and hypoparathyroidism as parathyroid hormone &lt;15 pg/mL. After comparing serum calcium levels on postoperative day 1 and intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy in the first period, an algorithm involving routine postoperative oral calcium and alfacalcidol administration in patients with intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy &lt;20 pg/mL was developed and tested during the second period. The rates of symptomatic hypocalcemia, readmission for hypocalcemia, and permanent hypoparathyroidism were compared between the 2 periods.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In the first period, 1,965 total thyroidectomies (1,548 women; mean age, 51 years) were performed, including 617 patients (31%) with central neck dissection for thyroid carcinoma. Of 314 patients (16%) who experienced symptomatic hypocalcemia, only 183 (58%) could be predicted using serum calcium levels on postoperative day 1 &lt;8.0 mg/dL. This rate increased to 96% (301 patients) when using intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and serum calcium levels on postoperative day 1 (P &lt; .001). Intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy alone could predict symptomatic hypocalcemia in 90% (282) of patients. Hypoparathyroidism was permanent in 20 patients (1%), with a greater predictive value of intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy over serum calcium levels on postoperative day 1 (18/20 [90%] vs 8/20 [40%], P &lt; .01). Using the intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy-based algorithm and preventive calcium supplementation in the second period of the study, 1,420 total thyroidectomies (1,106 women; mean age, 50 years) were performed, including 392 (28%) cases with central neck dissection for thyroid carcinoma. Only 2.3% (32) patients developed a symptomatic hypocalcemia compared with 16% during the first period (P &lt; .001). Thirty-eight patients (2.7%) experienced readmission after total thyroidectomy before implementation of the supplementation protocol in our study compared with 2 patients (0.01%) after we began using the protocol (P &lt; .001). There was no significant difference in permanent hypoparathyroidism between the 2 periods (1.3% vs 1%) (P = .8).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The parathyroid hormone-based algorithm determined by intraoperative parathyroid hormone levels 20 minutes after total thyroidectomy and routine preventive administration of oral calcium/calcitriol reduced the risk o","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108933"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Education of trauma patients on opioids and pain management: A quality improvement project. 对外伤患者进行阿片类药物和疼痛管理教育:质量改进项目。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-10 DOI: 10.1016/j.surg.2024.09.006
Carolina Chu, Braden Rolig, Dana M van der Heide, Sharon Joseph, Colette Galet, Dionne A Skeete

Background: Our acute care surgery team sustainably launched a pain management quality improvement project to reduce opioid prescriptions without affecting pain control in our elective surgery patients that was adopted on the inpatient acute care surgery service. Consequently, we implemented patient education on opioids and pain management aiming at decreasing opioid use without compromising pain management for acutely injured patients on the trauma service.

Methods: Trauma patients admitted from August 1, 2021, to July 31, 2022, and discharged to home were included. Pain management education started on February 2022. Demographics, injury severity scores (ISSs), preadmission opioid and adjunct use, and type/dose of opioids and nonopioid adjuncts prescribed 24 hours predischarge and at discharge were collected. Opioids were converted to oral morphine milligram equivalents (MME). Phone calls for pain and opioid prescription refills were collected. The pre- and posteducation groups were compared using univariate analysis. Multivariate analyses were conducted to identify factors associated with phone calls for pain and opioid refills.

Results: Three hundred sixty-eight patients were included, 200 pre- and 168 posteducation. MME prescribed at discharge was positively associated with 24-hour predischarge MME (B = 0.010 [0.007-0.012], P < .001) and negatively associated with preinjury opioid use (B = -0.405 [-0.80 to -0.008], P = .045). Patient education led to an increased number of adjuncts prescribed (P < .008), decreased phone calls for pain (OR = 0.356 [0.165-0.770], P = .009), and decreased opioid refills (OR = 0.297 [0.131-0.675], P = .004), but no change in opioid prescriptions.

Conclusion: Patient education on opioids and pain management led to decreased phone calls for inadequate pain management and decreased number of opioid refills.

背景:我们的急诊外科团队持续开展了一项疼痛管理质量改进项目,旨在减少阿片类药物处方,同时不影响择期手术患者的疼痛控制。因此,我们开展了关于阿片类药物和疼痛管理的患者教育,旨在减少阿片类药物的使用,同时不影响创伤科急性损伤患者的疼痛管理:方法:纳入 2021 年 8 月 1 日至 2022 年 7 月 31 日期间入院并出院回家的创伤患者。疼痛管理教育从 2022 年 2 月开始。研究人员收集了患者的人口统计学资料、受伤严重程度评分(ISS)、入院前阿片类药物和辅助药物的使用情况,以及出院前 24 小时和出院时阿片类药物和非阿片类辅助药物的类型/剂量。阿片类药物被转换为口服吗啡毫克当量(MME)。此外,还收集了有关疼痛和阿片类药物处方续订的电话记录。通过单变量分析比较了受教育前和受教育后两组的情况。进行了多变量分析,以确定与疼痛电话和阿片类药物续药相关的因素:结果:共纳入了 368 名患者,其中 200 名是接受教育前的患者,168 名是接受教育后的患者。出院时开具的MME与出院前24小时的MME呈正相关(B = 0.010 [0.007-0.012],P < .001),与受伤前阿片类药物的使用呈负相关(B = -0.405 [-0.80 to -0.008],P = .045)。通过对患者进行教育,开具的辅助用药数量增加(P < .008),疼痛电话减少(OR = 0.356 [0.165-0.770],P = .009),阿片类药物续药减少(OR = 0.297 [0.131-0.675],P = .004),但阿片类药物处方没有变化:结论:通过对患者进行阿片类药物和疼痛管理方面的教育,减少了因疼痛管理不当而打来的电话,也减少了阿片类药物的续订数量。
{"title":"Education of trauma patients on opioids and pain management: A quality improvement project.","authors":"Carolina Chu, Braden Rolig, Dana M van der Heide, Sharon Joseph, Colette Galet, Dionne A Skeete","doi":"10.1016/j.surg.2024.09.006","DOIUrl":"10.1016/j.surg.2024.09.006","url":null,"abstract":"<p><strong>Background: </strong>Our acute care surgery team sustainably launched a pain management quality improvement project to reduce opioid prescriptions without affecting pain control in our elective surgery patients that was adopted on the inpatient acute care surgery service. Consequently, we implemented patient education on opioids and pain management aiming at decreasing opioid use without compromising pain management for acutely injured patients on the trauma service.</p><p><strong>Methods: </strong>Trauma patients admitted from August 1, 2021, to July 31, 2022, and discharged to home were included. Pain management education started on February 2022. Demographics, injury severity scores (ISSs), preadmission opioid and adjunct use, and type/dose of opioids and nonopioid adjuncts prescribed 24 hours predischarge and at discharge were collected. Opioids were converted to oral morphine milligram equivalents (MME). Phone calls for pain and opioid prescription refills were collected. The pre- and posteducation groups were compared using univariate analysis. Multivariate analyses were conducted to identify factors associated with phone calls for pain and opioid refills.</p><p><strong>Results: </strong>Three hundred sixty-eight patients were included, 200 pre- and 168 posteducation. MME prescribed at discharge was positively associated with 24-hour predischarge MME (B = 0.010 [0.007-0.012], P < .001) and negatively associated with preinjury opioid use (B = -0.405 [-0.80 to -0.008], P = .045). Patient education led to an increased number of adjuncts prescribed (P < .008), decreased phone calls for pain (OR = 0.356 [0.165-0.770], P = .009), and decreased opioid refills (OR = 0.297 [0.131-0.675], P = .004), but no change in opioid prescriptions.</p><p><strong>Conclusion: </strong>Patient education on opioids and pain management led to decreased phone calls for inadequate pain management and decreased number of opioid refills.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108844"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of postoperative complications on gastric cancer survival. 术后并发症对胃癌存活率的影响。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-20 DOI: 10.1016/j.surg.2024.09.031
Ayato Obana, Kenichi Iwasaki, Tatsushi Suwa

Background: Long-term implications of postoperative complications, particularly non-cancer-related mortality in patients with gastric cancer following gastrectomy, remain unclear. We aimed to evaluate the impact of these complications on non-cancer-related deaths.

Methods: A cohort of 236 patients who underwent curative gastrectomy for gastric cancer in a Japanese hospital was divided based on complications classified as Clavien-Dindo grade II or higher. The Kaplan-Meier method, log-rank tests, and Cox hazard ratio analysis were used to evaluate recurrence-free survival and overall survival and to identify complications and survival predictors.

Results: Delirium was the most common complication (21 of 52 patients). A significant difference was observed in the overall survival (with complications, 3-year: 58.1% and 5-year: 51.6%; without complications, 3-year: 82.3% and 5-year: 73.6%; P < .001) but not in recurrence-free survival (with complications, 3-year: 77.8% and 5-year: 77.8%; without complications, 3-year: 87.5% and 5-year: 85.2%). Non-cancer-related deaths, predominantly resulting from pneumonia, were more prevalent in the complications group than in the noncomplications group. Factors, including high American Society of Anesthesiologists Physical Status scores, blood transfusion, open surgery, male sex, total gastrectomy, and a history of neurologic/psychiatric disease, were independently associated with decreased overall survival.

Conclusion: Postoperative complications affect long-term prognosis, resulting in decreased overall survival and increased noncancer mortality. Proactive strategies, including optimizing preoperative management, preventing complications, and postdischarge interventions, are essential, with a focus on pulmonary disease prevention to improve prognosis after gastrectomy.

背景:胃切除术后并发症的长期影响,尤其是胃癌患者的非癌症相关死亡率仍不清楚。我们旨在评估这些并发症对非癌症相关死亡的影响:方法:我们将一家日本医院的 236 名接受胃癌根治性切除术的患者按照克拉维恩-丁度(Clavien-Dindo)II 级或更高级别并发症进行了分类。采用卡普兰-梅耶法、对数秩检验和考克斯危险比分析评估无复发生存率和总生存率,并确定并发症和生存预测因素:谵妄是最常见的并发症(52 例患者中有 21 例)。结果:谵妄是最常见的并发症(52 例患者中有 21 例):58.1%和5年3年:58.1%,5年:51.6%;无并发症,3年:82.3%,5年:51.6%:82.3%,5 年:73.6%;P73.6%; P 结论:术后并发症会影响长期预后,导致总生存率下降和非癌症死亡率上升。必须采取积极的策略,包括优化术前管理、预防并发症和出院后干预,重点是预防肺部疾病,以改善胃切除术后的预后。
{"title":"Impact of postoperative complications on gastric cancer survival.","authors":"Ayato Obana, Kenichi Iwasaki, Tatsushi Suwa","doi":"10.1016/j.surg.2024.09.031","DOIUrl":"10.1016/j.surg.2024.09.031","url":null,"abstract":"<p><strong>Background: </strong>Long-term implications of postoperative complications, particularly non-cancer-related mortality in patients with gastric cancer following gastrectomy, remain unclear. We aimed to evaluate the impact of these complications on non-cancer-related deaths.</p><p><strong>Methods: </strong>A cohort of 236 patients who underwent curative gastrectomy for gastric cancer in a Japanese hospital was divided based on complications classified as Clavien-Dindo grade II or higher. The Kaplan-Meier method, log-rank tests, and Cox hazard ratio analysis were used to evaluate recurrence-free survival and overall survival and to identify complications and survival predictors.</p><p><strong>Results: </strong>Delirium was the most common complication (21 of 52 patients). A significant difference was observed in the overall survival (with complications, 3-year: 58.1% and 5-year: 51.6%; without complications, 3-year: 82.3% and 5-year: 73.6%; P < .001) but not in recurrence-free survival (with complications, 3-year: 77.8% and 5-year: 77.8%; without complications, 3-year: 87.5% and 5-year: 85.2%). Non-cancer-related deaths, predominantly resulting from pneumonia, were more prevalent in the complications group than in the noncomplications group. Factors, including high American Society of Anesthesiologists Physical Status scores, blood transfusion, open surgery, male sex, total gastrectomy, and a history of neurologic/psychiatric disease, were independently associated with decreased overall survival.</p><p><strong>Conclusion: </strong>Postoperative complications affect long-term prognosis, resulting in decreased overall survival and increased noncancer mortality. Proactive strategies, including optimizing preoperative management, preventing complications, and postdischarge interventions, are essential, with a focus on pulmonary disease prevention to improve prognosis after gastrectomy.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108873"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of mortality in patients requiring reoperative open-heart surgery. 需要再次进行开胸手术的患者的死亡风险。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-10-18 DOI: 10.1016/j.surg.2024.09.010
Hannah Calvelli, Mohammed Abul Kashem, Katherine Hanna, Masashi Azuma, Ke Cheng, Ravishankar Raman, Hiromu Kehara, Yoshiya Toyoda

Background: Improvements in surgical techniques and perioperative care as well as increased patient life expectancies have led cardiothoracic surgeons to perform more complex operations, including reoperative open-heart surgeries. However, there is debate as to which patients are appropriate operative candidates for reoperative procedures.

Methods: This is a retrospective, single-center study of patients who underwent reoperative open-heart surgery via median sternotomy or thoracotomy over a 10-year period. Patients with previous ventricular assist device or heart transplant were excluded. Patients were stratified by age <65 years compared with age ≥65 years for analysis. Survival was assessed using Kaplan-Meier curves and log-rank tests. Multivariate analysis was performed with Cox proportional hazards regression.

Results: A total of 250 patients underwent reoperative open-heart surgery at our center from 2012 to 2022. In total, 176 patients underwent valve surgery, 53 underwent coronary artery bypass grafting, 31 underwent aortic surgery, and 29 underwent other operations. The overall mortality rate was 13.6% at 30 days and 21.2% at 1-year postoperatively. Patients ≥65 years old had a greater average survival compared with patients <65 years old (5.0 vs 4.1 years, P = .046). However, there were no differences in survival by age when patients were stratified by procedure, either coronary artery bypass grafting (P = .29) or valve surgery (P = .16). On multivariate analysis, reoperative valve surgery, intraoperative use of extracorporeal membrane oxygenation, and a greater number of reoperative surgeries were associated with lower survival.

Conclusion: Patients undergoing reoperative open-heart surgery are clinically complex and had lower survival with each subsequent reoperation.

背景:手术技术和围手术期护理的改进以及患者预期寿命的延长促使心胸外科医生进行更复杂的手术,包括再手术开胸手术。然而,对于哪些患者适合再次手术还存在争议:这是一项回顾性的单中心研究,研究对象是 10 年内通过胸骨正中切开术或胸廓切开术接受再手术开胸手术的患者。曾使用过心室辅助装置或接受过心脏移植手术的患者被排除在外。根据年龄对患者进行分层:从2012年到2022年,共有250名患者在本中心接受了再手术开胸手术。其中,176 名患者接受了瓣膜手术,53 名患者接受了冠状动脉旁路移植手术,31 名患者接受了主动脉手术,29 名患者接受了其他手术。术后30天的总死亡率为13.6%,术后1年的总死亡率为21.2%。≥65岁患者的平均存活率高于结论:再次接受开胸手术的患者临床情况复杂,每次再次手术的存活率都较低。
{"title":"Risk of mortality in patients requiring reoperative open-heart surgery.","authors":"Hannah Calvelli, Mohammed Abul Kashem, Katherine Hanna, Masashi Azuma, Ke Cheng, Ravishankar Raman, Hiromu Kehara, Yoshiya Toyoda","doi":"10.1016/j.surg.2024.09.010","DOIUrl":"10.1016/j.surg.2024.09.010","url":null,"abstract":"<p><strong>Background: </strong>Improvements in surgical techniques and perioperative care as well as increased patient life expectancies have led cardiothoracic surgeons to perform more complex operations, including reoperative open-heart surgeries. However, there is debate as to which patients are appropriate operative candidates for reoperative procedures.</p><p><strong>Methods: </strong>This is a retrospective, single-center study of patients who underwent reoperative open-heart surgery via median sternotomy or thoracotomy over a 10-year period. Patients with previous ventricular assist device or heart transplant were excluded. Patients were stratified by age <65 years compared with age ≥65 years for analysis. Survival was assessed using Kaplan-Meier curves and log-rank tests. Multivariate analysis was performed with Cox proportional hazards regression.</p><p><strong>Results: </strong>A total of 250 patients underwent reoperative open-heart surgery at our center from 2012 to 2022. In total, 176 patients underwent valve surgery, 53 underwent coronary artery bypass grafting, 31 underwent aortic surgery, and 29 underwent other operations. The overall mortality rate was 13.6% at 30 days and 21.2% at 1-year postoperatively. Patients ≥65 years old had a greater average survival compared with patients <65 years old (5.0 vs 4.1 years, P = .046). However, there were no differences in survival by age when patients were stratified by procedure, either coronary artery bypass grafting (P = .29) or valve surgery (P = .16). On multivariate analysis, reoperative valve surgery, intraoperative use of extracorporeal membrane oxygenation, and a greater number of reoperative surgeries were associated with lower survival.</p><p><strong>Conclusion: </strong>Patients undergoing reoperative open-heart surgery are clinically complex and had lower survival with each subsequent reoperation.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108848"},"PeriodicalIF":3.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1